Crinetics Pharmaceuticals, Inc.
CRNXDelisted Sep 1, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001658247
Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Crinetics Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 172
- +33 vs. Q2 2023
- Shares held
- 68.5M
- +14.5M (+26.9%) vs. Q2 2023
- Total value
- $2.04B
- +$1.07B (+109.5%) vs. Q2 2023
- New holders
- 52
- 81 more added
- Sold out
- 19
- 29 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 267 | $4.63B |
| Q1 2026 | 244 | $4.46B |
| Q4 2025 | 242 | $5.20B |
| Q3 2025 | 225 | $4.49B |
| Q2 2025 | 222 | $3.01B |
| Q1 2025 | 227 | $3.42B |
| Q4 2024 | 247 | $5.10B |
| Q3 2024 | 235 | $4.32B |
| Q2 2024 | 234 | $3.69B |
| Q1 2024 | 203 | $3.76B |
| Q4 2023 | 181 | $2.51B |
| Q3 2023 | 172 | $2.04B |
| Q2 2023 | 140 | $974.1M |
| Q1 2023 | 129 | $884.3M |
| Q4 2022 | 122 | $1.00B |
| Q3 2022 | 122 | $1.01B |
| Q2 2022 | 111 | $944.5M |
| Q1 2022 | 116 | $997.4M |
| Q4 2021 | 118 | $1.26B |
| Q3 2021 | 94 | $708.2M |
| Q2 2021 | 83 | $616.9M |
| Q1 2021 | 80 | $465.3M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Crinetics Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Parkman Healthcare Partners LLC | 100,000 | $2.97M | 0.54% | +100,000 | New |
| Ghisallo Capital Management LLC | 100,000 | $2.97M | 0.30% | +100,000 | New |
| Ghost Tree Capital, LLC | 101,443 | $3.02M | 1.46% | +101,443 | New |
| Rhumbline Advisers | 106,554 | $3.17M | 0.00% | +16,400+18.2% | Added |
| Simplex Trading, LLC | 110,376 | $3.28M | 0.12% | +107,831+4,237.0% | Added |
| Barclays PLC | 113,282 | $3.37M | 0.00% | +21,189+23.0% | Added |
| Simplify Asset Management Inc. | 115,000 | $3.42M | 0.56% | +115,000 | New |
| Swiss National Bank | 116,400 | $3.46M | 0.00% | +34,200+41.6% | Added |
| Prudential Financial Inc | 132,629 | $3.89M | 0.01% | +60,864+84.8% | Added |
| Franklin Resources Inc | 138,825 | $4.13M | 0.00% | +340.0% | Added |
| TD Asset Management Inc | 139,426 | $4.15M | 0.01% | +80,526+136.7% | Added |
| New Leaf Venture Partners, L.L.C. | 141,000 | $4.19M | 5.38% | 00.0% | Unchanged |
| Woodline Partners LP | 150,000 | $4.46M | 0.05% | +150,000 | New |
| First Manhattan Co | 152,200 | $4.53M | 0.02% | 00.0% | Unchanged |
| Bank of America Corp | 154,900 | $4.61M | 0.00% | +34,526+28.7% | Added |
| Citadel Advisors LLC | 159,236 | $4.74M | 0.01% | −82,492−34.1% | Reduced |
| Renaissance Technologies LLC | 163,700 | $4.87M | 0.01% | +163,700 | New |
| Boothbay Fund Management, LLC | 167,238 | $4.97M | 0.18% | +70,433+72.8% | Added |
| Invesco Ltd. | 177,373 | $5.28M | 0.00% | +139,796+372.0% | Added |
| Rafferty Asset Management, LLC | 197,741 | $5.88M | 0.03% | +59,555+43.1% | Added |
| Integral Health Asset Management, LLC | 200,000 | $5.95M | 0.84% | +200,000 | New |
| Silverarc Capital Management, LLC | 220,000 | $6.54M | 2.44% | +220,000 | New |
| Logos Global Management LP | 250,000 | $7.43M | 1.06% | +250,000 | New |
| Altium Capital Management LP | 262,000 | $7.79M | 4.51% | +127,000+94.1% | Added |
| Schonfeld Strategic Advisors LLC | 277,208 | $8.24M | 0.08% | +277,208 | New |
| Millennium Management LLC | 282,599 | $8.40M | 0.01% | +240,071+564.5% | Added |
| BNP Paribas Arbitrage, SA | 304,120 | $9.04M | 0.02% | +244,960+414.1% | Added |
| Laurion Capital Management LP | 346,637 | $10.3M | 0.27% | +346,637 | New |
| Vivo Capital, LLC | 350,000 | $10.4M | 1.29% | +350,000 | New |
| Farallon Capital Management, L.L.C. | 361,904 | $10.8M | 0.06% | +361,904 | New |
| Opaleye Management Inc. | 370,000 | $11.0M | 3.62% | −475,000−56.2% | Reduced |
| Ensign Peak Advisors, Inc | 384,685 | $11.4M | 0.02% | +114,416+42.3% | Added |
| Two Sigma Investments, LP | 401,953 | $12.0M | 0.03% | +310,418+339.1% | Added |
| Nuveen Asset Management, LLC | 410,941 | $12.2M | 0.00% | +67,762+19.7% | Added |
| Walleye Capital LLC | 434,910 | $12.9M | 0.19% | +121,312+38.7% | Added |
| Affinity Asset Advisors, LLC | 450,000 | $13.4M | 4.37% | +450,000 | New |
| Charles Schwab Investment Management Inc | 461,303 | $13.7M | 0.00% | +110,565+31.5% | Added |
| 5AM Venture Management, LLC | 462,286 | $13.7M | 3.96% | −400,000−46.4% | Reduced |
| MPM Oncology Impact Management LP | 479,053 | $14.2M | 3.80% | 00.0% | Unchanged |
| GW&K Investment Management, LLC | 482,942 | $14.4M | 0.14% | −102,798−17.6% | Reduced |
| Bank of New York Mellon Corp | 492,047 | $14.6M | 0.00% | +28,629+6.2% | Added |
| Commodore Capital LP | 500,000 | $14.9M | 1.74% | +500,000 | New |
| Morgan Stanley | 511,321 | $15.2M | 0.00% | −234,838−31.5% | Reduced |
| Goldman Sachs Group Inc | 552,598 | $16.4M | 0.00% | −62,248−10.1% | Reduced |
| Janus Henderson Group PLC | 588,378 | $17.5M | 0.01% | +117,642+25.0% | Added |
| Northern Trust Corp | 597,324 | $17.8M | 0.00% | +106,594+21.7% | Added |
| Avidity Partners Management LP | 610,000 | $18.1M | 0.73% | +610,000 | New |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 633,364 | $18.8M | 0.06% | −7,981−1.2% | Reduced |
| Dimensional Fund Advisors LP | 744,816 | $22.2M | 0.01% | +225,707+43.5% | Added |
| Ikarian Capital, LLC | 792,920 | $23.6M | 8.75% | +317,920+66.9% | Added |
| Eventide Asset Management, LLC | 1,018,782 | $30.3M | 0.55% | +584,014+134.3% | Added |
| Novo Holdings A/S | 1,100,000 | $32.7M | 2.42% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,101,904 | $32.8M | 1.91% | +1,101,904 | New |
| Saturn V Capital Management LLC | 1,126,579 | $33.5M | 14.02% | +187,902+20.0% | Added |
| Perceptive Advisors LLC | 1,263,732 | $37.6M | 1.26% | −683,205−35.1% | Reduced |
| Geode Capital Management, LLC | 1,269,674 | $37.8M | 0.00% | +282,184+28.6% | Added |
| Bain Capital Life Sciences Investors, LLC | 1,275,552 | $37.9M | 4.24% | −1,030,006−44.7% | Reduced |
| Jennison Associates LLC | 1,433,691 | $42.6M | 0.04% | +972,194+210.7% | Added |
| EcoR1 Capital, LLC | 1,530,263 | $45.5M | 1.55% | +200,000+15.0% | Added |
| First Light Asset Management, LLC | 1,583,329 | $47.1M | 4.47% | +26,107+1.7% | Added |
| Frazier Life Sciences Management, L.P. | 1,589,931 | $47.3M | 3.14% | +175,108+12.4% | Added |
| T. Rowe Price Investment Management, Inc. | 1,640,692 | $48.8M | 0.03% | +676,687+70.2% | Added |
| FMR LLC | 2,140,861 | $63.7M | 0.01% | +1,057,947+97.7% | Added |
| Paradigm Biocapital Advisors LP | 2,178,737 | $64.8M | 4.42% | +783,735+56.2% | Added |
| Price T Rowe Associates Inc | 2,578,199 | $76.7M | 0.01% | +1,149,289+80.4% | Added |
| State Street Corp | 2,852,720 | $84.8M | 0.00% | +614,985+27.5% | Added |
| OrbiMed Advisors LLC | 2,896,074 | $86.1M | 1.99% | −1,054,722−26.7% | Reduced |
| Vanguard Group Inc | 3,407,035 | $101.3M | 0.00% | +674,301+24.7% | Added |
| Wellington Management Group LLP | 3,640,235 | $108.3M | 0.02% | +38,523+1.1% | Added |
| Point72 Asset Management, L.P. | 4,225,300 | $125.7M | 0.43% | +4,225,300 | New |
| BlackRock Inc. | 4,845,717 | $144.1M | 0.00% | +245,231+5.3% | Added |
| Driehaus Capital Management LLC | 5,132,287 | $152.6M | 1.98% | −165,801−3.1% | Reduced |
| Finepoint Capital LP | 0 | $0 | 0.00% | −797,527−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −650,312−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −225,000−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −149,100−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −55,798−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −47,192−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −32,623−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −32,562−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −29,089−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −22,839−100.0% | Sold out |
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −19,354−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −17,117−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −14,909−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −12,327−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −10,442−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −3,900−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −1,150−100.0% | Sold out |
| CarsonAllaria Wealth Management, Ltd. | 0 | $0 | 0.00% | −190−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Tekla Capital Management LLC | – | – | – | – | Not filed |